Exploring the inherent susceptibility of cancer-associated fibroblasts to oncolytic virus infection.

INTRODUCTION: Oncolytic virus (OV) therapy represents a promising approach currently undergoing (pre)-clinical testing for several cancers. Until recently, it was thought that the tropism of oncolytic viruses was restricted to epithelial cancer cells…

Preview only. Read the full abstract at the source